Share

January 2021; 8 (1) EditorialOpen Access

Obesity's role in MS

An intervention target with possible interactions

Kathryn C. Fitzgerald, Ellen M. Mowry
First published December 15, 2020, DOI: https://doi.org/10.1212/NXI.0000000000000932
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
417

Share

Article Information

vol. 8 no. 1 e932
DOI: 
https://doi.org/10.1212/NXI.0000000000000932
PubMed: 
33439854
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • First Published December 15, 2020.
Copyright & Usage: 
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Kathryn C. Fitzgerald, ScD and
    2. Ellen M. Mowry, MD, MCR
  1. Kathryn C. Fitzgerald, ScD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NIMH 1-K01MH121582-01, PI, 2019-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Career Transition Fellowship (TA-1805-31136) from the National MS Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ellen M. Mowry, MD, MCR
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. UptoDate chapter editor

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Free glatiramer acetate for a clinical trial from Teva Neuroscience. (2)Research funding paid to my institution from Biogen and Genzyme (for investigator-initiated studies). (3) Site PI of studies sponsored by Biogen

    Research Support, Government Entities:

    1. (1)Department of Defense, W81XWH-16-1-0693 (2)National Institutes of Health, 1R01NR018851-01A1

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. National Multiple Sclerosis Society. 2. Patient-Centered Outcomes Research Institute (PCORI)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (K.C.F., E.M.M.), Johns Hopkins School of Medicine; and Department of Epidemiology (K.C.F., E.M.M.), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  1. Correspondence
    Dr. Mowry emowry1{at}jhmi.edu
View Full Text

Article usage

Article usage: December 2020 to April 2023

AbstractFullPdfSource
Dec 2020010620Highwire
Jan 2021417947Highwire
Feb 202146713Highwire
Mar 202104815Highwire
Apr 202122916Highwire
May 202112815Highwire
Jun 202156920Highwire
Jul 202111916Highwire
Aug 202101111Highwire
Sep 202121617Highwire
Oct 202104539Highwire
Nov 202102229Highwire
Dec 20210136Highwire
Jan 202231510Highwire
Feb 20221156Highwire
Mar 20220137Highwire
Apr 20220107Highwire
May 202211911Highwire
Jun 20220149Highwire
Jul 20220155Highwire
Aug 20220237Highwire
Sep 202202011Highwire
Oct 202202017Highwire
Nov 202204319Highwire
Dec 202211913Highwire
Jan 202302310Highwire
Feb 20230239Highwire
Mar 2023043Highwire
Apr 20230159Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles